R
Rosie Bradley
Researcher at University of Oxford
Publications - 24
Citations - 1917
Rosie Bradley is an academic researcher from University of Oxford. The author has contributed to research in topics: Breast cancer & Randomized controlled trial. The author has an hindex of 9, co-authored 17 publications receiving 1200 citations. Previous affiliations of Rosie Bradley include Edinburgh Cancer Research Centre & Clinical Trial Service Unit.
Papers
More filters
Journal ArticleDOI
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
Bernard Asselain,William E. Barlow,John M. S. Bartlett,Jonas Bergh,Elizabeth Bergsten-Nordström,Judith M Bliss,Francesco Boccardo,Clare Boddington,Jan Bogaerts,Gianni Bonadonna,Rosie Bradley,Etienne Brain,Jeremy P Braybrooke,Philippe Broët,John Bryant,Julie Ann Burrett,David Cameron,Mike Clarke,Alan S. Coates,Robert E. Coleman,Raoul Charles Coombes,C Correa,J. Costantino,Jack Cuzick,David N. Danforth,Nancy E. Davidson,C Davies,Lucy Davies,Angelo Di Leo,David Dodwell,Mitch Dowsett,Fran Duane,Vaughan Evans,Marianne Ewertz,Bernard Fisher,John F. Forbes,Leslie G. Ford,Jean-Claude Gazet,Richard D. Gelber,Lucy Gettins,Luca Gianni,Michael Gnant,Jon Godwin,Aron Goldhirsch,Pamela J. Goodwin,Richard Gray,Daniel F. Hayes,Catherine Hill,James N. Ingle,Reshma Jagsi,Raimund Jakesz,Sam James,Wolfgang Janni,Hui Liu,Z Liu,Caroline Lohrisch,Sibylle Loibl,Liz MacKinnon,Andreas Makris,Eleftherios P. Mamounas,Gurdeep S. Mannu,Miguel Martín,Simone Mathoulin,Louis Mauriac,Paul McGale,Theresa McHugh,Philip Morris,Hirofumi Mukai,Larry Norton,Yasuo Ohashi,Ivo A. Olivotto,Soon Paik,Hongchao Pan,Richard Peto,Martine Piccart,Lori J. Pierce,Philip Poortmans,Trevor J. Powles,Kathy Pritchard,Joseph Ragaz,Vinod Raina,Peter M. Ravdin,Simon Read,Meredith M. Regan,John F.R. Robertson,Emiel J. Th. Rutgers,Suzy Scholl,Dennis J. Slamon,Lidija Sölkner,Joseph A. Sparano,Seth M. Steinberg,Rosemary Sutcliffe,Sandra M. Swain,Carolyn W. Taylor,Andrew Tutt,Pinuccia Valagussa,Cornelis J.H. van de Velde,Jos van der Hage,Giuseppe Viale,Gunter von Minckwitz,Yaochen Wang,Zhe Wang,Xiang Wang,Timothy J. Whelan,Nicholas Wilcken,Eric P. Winer,Norman Wolmark,William C. Wood,Milvia Zambetti,Jo Anne Zujewski +109 more
TL;DR: Tumours downsized by NACT might have higher local recurrence after breast-conserving therapy than might tumours of the same dimensions in women who have not received NACT.
Journal ArticleDOI
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
Joop P. W. van den Bergh,Kathleen I. Pritchard,KS Albain,Stewart J. Anderson,Rodrigo Arriagada,William E. Barlow,W. Bergsten-Nordström,Judith M Bliss,Francesco Boccardo,Rosie Bradley,Marc Buyse,David Cameron,Mike Clarke,M. Coates,Robert E. Coleman,C Correa,J. Costantino,Jack Cuzick,Neville Davidson,C Davies,A. Di Leo,Mitchell Dowsett,Marianne Ewertz,John F. Forbes,R. D. Gelber,R. Geyer,R. Gianni,M. Gnant,A. Goldhirsch,Richard Gray,Daniel F. Hayes,C. Hill,JN Ingle,Wolfgang Janni,Elizabeth MacKinnon,M. Martin,Paul McGale,Larry Norton,Yasuo Ohashi,Soonmyung Paik,Hongchao Pan,E. A. Perez,Richard Peto,R. Piccart,Lori J. Pierce,Vinod Raina,Peter M. Ravdin,J.F.R. Robertson,E.J.T. Rutgers,Joseph A. Sparano,Sandra M. Swain,Carolyn W. Taylor,Giuseppe Viale,G. von Minckwitz,Xiang Wang,Timothy J. Whelan,Nicholas Wilcken,Eric P. Winer,Norman Wolmark,William C. Wood +59 more
TL;DR: In this paper, the authors conducted a collaborative meta-analysis to clarify the risks and benefits of adjuvant bisphosphonate treatment in early breast cancer, and found that the reduction in bone recurrence was more definite (0.73-0.94; 2p=0.004).
Journal ArticleDOI
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials
Richard Gray,Rosie Bradley,Jeremy P Braybrooke,Z Liu,Richard Peto,Lucy Davies,David Dodwell,Paul McGale,Hongchao Pan,Carolyn W. Taylor,William E. Barlow,Judith M Bliss,Paolo Bruzzi,David Cameron,George Fountzilas,Sibylle Loibl,John R. Mackey,Miguel Martín,Lucia Del Mastro,Volker Möbus,Valentina Nekljudova,Sabino De Placido,Sandra M. Swain,Michael Untch,Kathleen I. Pritchard,Jonas Bergh,Larry Norton,Clare Boddington,Julie Ann Burrett,Mike Clarke,C Davies,Fran Duane,Vaughan Evans,Lucy Gettins,Jon Godwin,Robert Kerrin Hills,Sam James,Hui Liu,Elizabeth MacKinnon,Gurdeep S. Mannu,Theresa McHugh,Philip Morris,Simon Read,Yaochen Wang,Zhe Wang,Peter A. Fasching,Nadia Harbeck,Pascal Piedbois,Michael Gnant,Guenther G. Steger,Angelo Di Leo,Stella Dolci,Prue Francis,Denis Larsimont,Jean Marie Nogaret,Catherine Philippson,Martine Piccart,Sabine C. Linn,Petronella Peer,Vivianne C. G. Tjan-Heijnen,Sonja Vliek,Dennis J. Slamon,John D. Bartlett,Vivien H.C. Bramwell,Bingshu E. Chen,Stephen Chia,Karen A. Gelmon,Paul E. Goss,Mark Levine,Wendy R. Parulekar,Joseph L. Pater,Eileen Rakovitch,Lois E. Shepherd,Dongsheng Tu,Timothy J. Whelan,Donald A. Berry,Gloria Broadwater,Constance Cirrincione,Hyman B. Muss,Raymond B. Weiss,Yi Shan,Yong Fu Shao,Xiang Wang,Binghe Xu,Dong-Bing Zhao,Harry Bartelink,Nina Bijker,Jan Bogaerts,Fatima Cardoso,Tanja Cufer,J.P. Julien,Philip Poortmans,Emiel J. Th. Rutgers,Cornelis J.H. van de Velde,Eva Carrasco,Miguel Angel Segui,Jens Uwe Blohmer,Serban Costa,Bernd Gerber,Christian Jackisch,Gunter von Minckwitz,Mario Giuliano,Michele De Laurentiis,Christina Bamia,Georgia-Angeliki Koliou,Dimitris Mavroudis,Roger A'Hern,Paul Ellis,Lucy Kilburn,James P Morden,John Yarnold,Mohammad Sadoon,Augustinus H Tulusan,Stewart J. Anderson,Gordon Bass,J. Costantino,James J. Dignam,Bernard Fisher,Charles E. Geyer,Eleftherios P. Mamounas,Soon Paik,Carol Redmond,D. Lawrence Wickerham,M. Venturini,Claudia Bighin,Simona Pastorino,Paolo Pronzato,Mario Roberto Sertoli,Theodorus Foukakis,Kathy S. Albain,Rodrigo Arriagada,Elizabeth Bergsten Nordström,Francesco Boccardo,Etienne Brain,Lisa A. Carey,Alan S. Coates,Robert E. Coleman,C Correa,Jack Cuzick,Nancy E. Davidson,Mitch Dowsett,Marianne Ewertz,John F. Forbes,Richard D. Gelber,Aron Goldhirsch,Pamela J. Goodwin,Daniel F. Hayes,Christopher Hill,James N. Ingle,Reshma Jagsi,Wolfgang Janni,Hirofumi Mukai,Yasuo Ohashi,Lori J. Pierce,Vinod Raina,Peter M. Ravdin,Daniel Rea,Meredith M. Regan,John F.R. Robertson,Joseph A. Sparano,Andrew Tutt,Giuseppe Viale,Nicholas Wilcken,Norman Wolmark,Wiliam Wood,Milvia Zambetti +165 more
TL;DR: Increasing the dose intensity of adjuvant chemotherapy by shortening the interval between treatment cycles, or by giving individual drugs sequentially rather than giving the same drugs concurrently, moderately reduces the 10-year risk of recurrence and death from breast cancer without increasing mortality from other causes.
Journal ArticleDOI
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
Rosie Bradley,Jeremy P Braybrooke,Richard Gray,Robert Kerrin Hills,Z Liu,Richard Peto,Lucy Davies,David Dodwell,Paul McGale,Hongchao Pan,Carolyn W. Taylor,Stewart J. Anderson,Richard D. Gelber,Luca Gianni,William Jacot,Heikki Joensuu,Alvaro Moreno-Aspitia,Martine Piccart,Michael F. Press,Edward Romond,Dennis J. Slamon,Vera J. Suman,Richard Berry,Clare Boddington,Mike Clarke,C Davies,Fran Duane,Vaughan Evans,Lucy Gettins,Jon Godwin,Sam James,Hui Liu,Elizabeth MacKinnon,Gurdeep S. Mannu,Theresa McHugh,Philip Morris,Simon Read,Ewan Straiton,Yaochen Wang,John Crown,Evandro de Azambuja,Suzette Delaloge,Helena Fung,Charles E. Geyer,Marc Spielmann,Pinuccia Valagussa,Kathy S. Albain,Rodrigo Arriagada,John D. Bartlett,Elizabeth Bergsten-Nordström,Judith M Bliss,Etienne Brain,Lisa A. Carey,Robert E. Coleman,Jack Cuzick,Nancy E. Davidson,Lucia Del Mastro,Angelo Di Leo,James J. Dignam,Mitch Dowsett,Bent Ejlertsen,Prue Francis,Michael Gnant,Matthew Bidwell Goetz,Pam Goodwin,Pat Halpin-Murphy,Daniel F. Hayes,Christopher Hill,Reshma Jagsi,Wolfgang Janni,Sibylle Loibl,Eleftherios P. Mamounas,Miguel Martín,Hirofumi Mukai,Valentina Nekljudova,Larry Norton,Yasuo Ohashi,Lori J. Pierce,Philip Poortmans,Vinod Raina,Daniel Rea,Meredith M. Regan,John F.R. Robertson,Emiel J. Th. Rutgers,Tanja Spanic,Joseph A. Sparano,Guenther G. Steger,Gong Tang,Masakazu Toi,Andrew Tutt,Giuseppe Viale,Xiang Wang,Timothy J. Whelan,Nicholas Wilcken,Norman Wolmark,David Cameron,Jonas Bergh,Kathleen I. Pritchard,Sandra M. Swain +98 more
TL;DR: In this paper, the authors investigated the long-term benefits and risks of adjuvant trastuzumab on breast cancer recurrence and cause-specific mortality, and did a collaborative meta-analysis of individual patient data from randomised trials.
Journal ArticleDOI
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial.
Robert Howard,Olga Zubko,Rosie Bradley,Emma Harper,Lynn Pank,John T. O'Brien,Chris Fox,Naji Tabet,Gill Livingston,Peter Bentham,Rupert McShane,Alistair Burns,Craig W. Ritchie,Suzanne Reeves,Simon Lovestone,Clive Ballard,Wendy Noble,Ramin Nilforooshan,Gordon K. Wilcock,Richard Gray +19 more
TL;DR: In this randomized clinical trial that included 544 participants, 24 months of minocycline treatment did not significantly delay progression of functional and cognitive impairment compared with placebo, meaning Minocy Cline is not a candidate for disease modification for patients with symptomatic Alzheimer disease.